ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 128 filers reported holding ANTARES PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $340,000 | +13.7% | 83,029 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $299,000 | -21.3% | 83,628 | -19.8% | 0.00% | 0.0% |
| Q3 2021 | $380,000 | -26.9% | 104,297 | -12.5% | 0.00% | 0.0% |
| Q2 2021 | $520,000 | +15.3% | 119,213 | +8.6% | 0.00% | 0.0% |
| Q1 2021 | $451,000 | +21.9% | 109,773 | +18.1% | 0.00% | 0.0% |
| Q4 2020 | $370,000 | +131.2% | 92,910 | +57.0% | 0.00% | – |
| Q3 2020 | $160,000 | -1.8% | 59,179 | 0.0% | 0.00% | – |
| Q2 2020 | $163,000 | -18.1% | 59,179 | -29.9% | 0.00% | -100.0% |
| Q1 2020 | $199,000 | -45.9% | 84,398 | +7.7% | 0.00% | 0.0% |
| Q4 2019 | $368,000 | +72.8% | 78,400 | +23.1% | 0.00% | – |
| Q3 2019 | $213,000 | +1.4% | 63,688 | 0.0% | 0.00% | – |
| Q2 2019 | $210,000 | +10.5% | 63,688 | +1.7% | 0.00% | – |
| Q1 2019 | $190,000 | +11.8% | 62,618 | 0.0% | 0.00% | – |
| Q4 2018 | $170,000 | -12.4% | 62,618 | +8.3% | 0.00% | – |
| Q3 2018 | $194,000 | +30.2% | 57,803 | 0.0% | 0.00% | – |
| Q2 2018 | $149,000 | +4.2% | 57,803 | -11.2% | 0.00% | – |
| Q1 2018 | $143,000 | +10.9% | 65,073 | 0.0% | 0.00% | – |
| Q4 2017 | $129,000 | -38.9% | 65,073 | 0.0% | 0.00% | – |
| Q3 2017 | $211,000 | +0.5% | 65,073 | 0.0% | 0.00% | – |
| Q2 2017 | $210,000 | +159.3% | 65,073 | -30.5% | 0.00% | – |
| Q1 2016 | $81,000 | -28.3% | 93,600 | 0.0% | 0.00% | – |
| Q4 2015 | $113,000 | -28.9% | 93,600 | 0.0% | 0.00% | – |
| Q3 2015 | $159,000 | -18.5% | 93,600 | 0.0% | 0.00% | – |
| Q2 2015 | $195,000 | -23.2% | 93,600 | 0.0% | 0.00% | -100.0% |
| Q1 2015 | $254,000 | +5.4% | 93,600 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $241,000 | +40.9% | 93,600 | 0.0% | 0.00% | – |
| Q3 2014 | $171,000 | -31.6% | 93,600 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $250,000 | -23.8% | 93,600 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $328,000 | -21.7% | 93,600 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $419,000 | +10.3% | 93,600 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $380,000 | -2.3% | 93,600 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $389,000 | – | 93,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,820,524 | $4,697,000 | 3.00% |
| ARMISTICE CAPITAL, LLC | 12,050,000 | $31,089,000 | 2.03% |
| Broadfin Capital, LLC | 4,623,247 | $11,928,000 | 1.88% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| MYCIO WEALTH PARTNERS, LLC | 2,433,500 | $6,278,000 | 0.65% |
| PERKINS CAPITAL MANAGEMENT INC | 317,500 | $819,000 | 0.59% |
| Brown Advisory Securities, LLC | 275,000 | $710,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 222,501 | $574,000 | 0.11% |
| Avenir Corp | 291,597 | $752,000 | 0.09% |